Virtu Financial’s Edesa Biotech EDSA Stock Holding History

Virtu Financial’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$137K	Buy	+26,275	New	+$78.8K	0.01%	1123
2022 Q1	–	Sell	-2,132	Closed	-$84K	–	1631
2021 Q4	$84K	Sell	2,132 -12,941	-86%	-$619K	0.01%	1199
2021 Q3	$779K	Buy	15,073 +12,368	+457%	+$481K	0.07%	293
2021 Q2	$100K	Buy	2,705 +400	+17%	+$16.2K	0.01%	1205
2021 Q1	$87K	Buy	+2,305	New	+$92.9K	0.01%	1351
2019 Q2	–	Sell	-380	Closed	-$17K	–	1548
2019 Q1	$17K	Buy	+380	New	+$18.7K	﹤0.01%	1295
2018 Q4	–	Sell	-389	Closed	-$23K	–	1651
2018 Q3	$23K	Buy	+389	New	+$24.8K	﹤0.01%	1396
2018 Q2	–	Sell	-36	Closed	-$9K	–	2086
2018 Q1	$9K	Buy	+36	New	+$8.9K	﹤0.01%	1855

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SRL

Scientech Research LLC Jersey City, New Jersey $120M AUM 73.62% 1-Year Est. Return

Virtu Financial's EDSA Position: Q1 2026 in Review

Virtu Financial opened a new position in Edesa Biotech (EDSA) in Q1 2026: 26,275 shares worth $137K. The stake represents 0.01% of the portfolio and ranks #1123 among its holdings. This is a return to the name: Virtu Financial previously reported a position in EDSA as recently as Q4 2021.

Virtu Financial first reported a position in EDSA in Q1 2018 and has held it in 8 quarters since. The position peaked at $779K in Q3 2021. 28 funds tracked by Wall St. Rank hold EDSA as of Q1 2026.

Virtu Financial held 26,275 shares of Edesa Biotech worth $137K as of Q1 2026.
Edesa Biotech was a new Virtu Financial position in Q1 2026.
Edesa Biotech made up 0.01% of Virtu Financial's portfolio in Q1 2026, its #1123 holding.
Virtu Financial first reported a position in Edesa Biotech in Q1 2018 and has held it in 8 quarters since.
Virtu Financial's Edesa Biotech position peaked at $779K in Q3 2021.
28 funds tracked by Wall St. Rank held Edesa Biotech as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.